Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in NUVB — Nuvation Bio Inc.

CIK 1423053 MIAMI, FL
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$11,293,713
+$2,433,101 QoQ
Shares Held
1,988,330
-3.7% QoQ
Ownership
0.566%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Derivatives in NUVB

reported options exposure · as of Jun 30, 2026
CallValue
$186,872
CallShares
32,900
PutValue
$566,864
PutShares
99,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. NUVB ranks #89 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in NUVB

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,293,713 1,988,330
2026-06-30 $186,872 32,900
2026-06-30 $566,864 99,800
2026-03-31 $712,140 166,000
2026-03-31 $8,860,612 2,065,411
2026-03-31 $318,318 74,200
2025-12-31 $3,092,096 345,100
2025-12-31 $1,198,848 133,800
2025-12-31 $1,209,591 134,999
2025-09-30 $8,526,476 2,304,453
2025-09-30 $79,920 21,600
2025-09-30 $1,212,490 327,700
2025-06-30 $208,260 106,800
2025-06-30 $120,900 62,000
2025-06-30 $10,789,302 5,532,976
2025-03-31 $270,160 153,500
2025-03-31 $3,706,288 2,105,846
2025-03-31 $8,096 4,600
2024-12-31 $3,192 1,200
2024-12-31 $593,446 223,100
2024-12-31 $5,793,378 2,177,962
2024-09-30 $7,328 3,200
2024-09-30 $226,023 98,700
2024-09-30 $6,316,641 2,758,359
2024-06-30 $18,980 6,500
2024-06-30 $28,324 9,700
2024-06-30 $5,828,953 1,996,217
2024-03-31 $10,556 2,900
2024-03-31 $7,642,524 2,099,595
2024-03-31 $147,784 40,600
2023-12-31 $604 400
2023-12-31 $7,248 4,800
2023-12-31 $4,495,725 2,977,302
2023-09-30 $268 200
2023-09-30 $3,282,806 2,449,856
2023-09-30 $33,098 24,700
2023-06-30 $4,341,025 2,411,681
2023-06-30 $9,000 5,000
2023-03-31 $4,747,383 2,859,870
2023-03-31 $166 100
2022-12-31 $10,204,859 5,315,031
2022-12-31 $1,728 900
2022-09-30 $12,641,987 5,643,745
2022-06-30 $18,216,040 5,622,235
2022-03-31 $31,482,272 5,985,223
2021-12-31 $46,786,303 5,504,271
2021-09-30 $151,088 15,200
2021-09-30 $56,114,172 5,645,289
2021-06-30 $59,599,724 6,401,689
2021-06-30 $358,435 38,500